Similar articles

• [Early detection of prostatic carcinoma: Is PSA screening suitable?].

  Kaulen H. Kaulen H. Dtsch Med Wochenschr. 2003 May 2;128(18):977. Dtsch Med Wochenschr. 2003. PMID: 12755136 German. No abstract available.
• Inter-relation between measurement of serum prostatic specific antigen and transrectal ultrasound in the diagnosis of benign prostatic hyperplasia and prostatic cancer.

  Clements R, Etherington RJ, Griffiths GJ, Peeling WB, Hughes H, Penney MD. Clements R, et al. Br J Urol. 1992 Aug;70(2):183-7. doi: 10.1111/j.1464-410x.1992.tb15700.x. Br J Urol. 1992. PMID: 1382795
• [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].

  Maksimov VA, Kamalov AA, Karpov VK, Riaboĭ AV, Prokhorov AV. Maksimov VA, et al. Urologiia. 2001 Mar-Apr;(2):37-40. Urologiia. 2001. PMID: 11490716 Russian.
• [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment].

  Pushkar' DIu, Rasner PI, Skobelev PP. Pushkar' DIu, et al. Urologiia. 2001 Nov-Dec;(6):48-54. Urologiia. 2001. PMID: 11785083 Review. Russian. No abstract available.
• The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer.

  Partin AW, Carter HB. Partin AW, et al. Urol Clin North Am. 1996 Nov;23(4):531-40. doi: 10.1016/s0094-0143(05)70333-5. Urol Clin North Am. 1996. PMID: 8948408 Review.